Valproic Acid

3 trials 3 recruiting

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

3 Recruiting

0 Completed trials

2 Sponsors

4 Countries

Phase II

Phase II: 3

Indications tested

Colorectal cancer metastatic 1

Sponsors using this IMP

IRCCS Istituto Nazionale Tumori Fondazione Pascale 2 Heidelberg University Hospital AöR 1

All trials

3 total

Randomized phase 2 study of Valproic acid combinEd with rechallenge anti-EGFR based regimen regimens in pretreated patients with RAS/BRAF wi… Recruiting

2024-514420-16-00 Phase II 1 country IRCCS Istituto Nazionale Tumori Fondazione Pascale
Long-term neuropsychologic outcome of pre-emptive mTOR inhibitor treatment in children with tuberous sclerosis complex (TSC) under 4 months … Recruiting

2022-502332-39-00 Phase II 2 countries Heidelberg University Hospital AöR
Randomized phase 2 study of Valproic acid combinEd with Simvastatin and gemcitabine/nab-paclitaxel-based regimens in untreated metastatic P… Recruiting

2024-518710-11-00 Phase II 2 countries IRCCS Istituto Nazionale Tumori Fondazione Pascale

Showing 1–3 of 3 trials

← All drugs A–Z